MedPath

Optimizing Adherence and Glycemia in Youth With New Insulin-dependent Diabetes Mellitus (IDDM)

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Registration Number
NCT00745342
Lead Sponsor
Joslin Diabetes Center
Brief Summary

This 2-year randomized, controlled trial examined the impact of a clinic-based, family teamwork intervention on glycemic control in youth with recently diagnosed type 1 diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria
  • 8 to 17 years old
  • Duration of type 1 diabetes between 2 months and 6 years
  • Residence in New England or New York
  • At least 1 outpatient visit in the past year
Exclusion Criteria
  • Major co-morbid psychiatric or medical illness in youth
  • Diagnosis of an active major psychiatric disorder in either parent
  • Diagnosis of a life-threatening medical illness in either parent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Glycemic control, assessed by hemoglobin A1c2 years

Change in A1c from baseline to 2 years, measured every 3 months

Secondary Outcome Measures
NameTimeMethod
Youth quality of life, measured using the youth PedsQL survey and the parent-proxy PedsQL survey2 years

Measured at baseline, 1 year, and 2 years

Diabetes-specific family conflict, measured using the Diabetes Family Conflict survey (youth and parent versions)2 years

Measured at baseline, 1 year, and 2 years

Parent involvement in diabetes management tasks, measured using the Diabetes Family Responsibility Questionnaire (youth and parent versions)2 years

Measured at baseline, 1 year, and 2 years

Trial Locations

Locations (1)

Joslin Diabetes Center

🇺🇸

Boston, Massachusetts, United States

Joslin Diabetes Center
🇺🇸Boston, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.